Glaxo to Evaluate Quantum Dot SNP Detection System

Jan 16, 2001

NEW YORK, Jan 16 - Quantum Dot said Tuesday that GlaxoSmithKline has agreed to help in evaluating the company’s SNP detection assays.

Financial terms of the deal were not disclosed. Andy Watson, vice president of systems at QDC, said the evaluation could potentially lead to a licensing agreement.

"They’ll be using their expertise to evaluate the data we generate and to see how applicable it is to their needs," said Watson.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Lamar Alexander Won't Seek Re-Election

Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

Second X Helping

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

Tracing the Bugs

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

This Week in PNAS

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

Main menu